OpenLegislation

Division 1 RISK ANALYSIS AND RISK MANAGEMENTF1

United Kingdom Repealed

Original text. Later amendments are not shown.

  1. 1.1Justification for the use of animal tissues or derivatives
  2. 1.2Assessment procedure
  3. 1.3Review of the assessment

Annotations

Textual amendments

F1

Repealed by Commission Regulation (EU) No 722/2012 of 8 August 2012 concerning particular requirements as regards the requirements laid down in Council Directives 90/385/EEC and 93/42/EEC with respect to active implantable medical devices and medical devices manufactured utilising tissues of animal origin (Text with EEA relevance).